YH14618

DRUG2 trials

Sponsors

Yuhan Corporation

Conditions

Degenerative Disc DiseaseDisc Degenerative Disease

Phase 1

Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease

CompletedNCT01526330

Yuhan CorporationDegenerative Disc Disease

Start: 2012-05-31End: 2014-07-31Updated: 2015-05-29

Phase 2

Clinical Trial of YH14618 in Patients With Degenerative Disc Disease

CompletedNCT02320019

Yuhan CorporationDisc Degenerative Disease

Start: 2015-03-31End: 2016-08-31Updated: 2016-11-10